Target intelligence / Profile preview

Phosphoglucomutase 2 (PGM2)

Target
PGM2
Molecular classification
Enzyme, Metabolic protein, α-D-phosphohexomutase superfamily
01

Overview

Phosphoglucomutase 2 (PGM2) is an enzyme of the α-D-phosphohexomutase superfamily, distinct from the classical phosphoglucomutase 1 (PGM1). It is most active on pentose phosphosugars, including ribose 1-phosphate and deoxyribose 1-phosphate, and shows a tissue-dependent expression pattern with highest levels in lung, spleen, and thymus. PGM2 catalyzes the reversible transfer of a phosphate group within sugars, which is essential for processes such as glycogen synthesis, glycogen breakdown, and nucleotide sugar metabolism. Like other phosphoglucomutases, it requires a phosphorylated serine residue for activity, and a divalent metal ion such as Mg²⁺ for optimal function. Structurally, PGM2 shares the four-domain “heart-shaped” fold typical for the superfamily and contains conserved motifs for substrate and metal binding. Though not yet a direct drug target, enzymes of this family are important for metabolic regulation, and dysfunction of related enzymes is linked to congenital metabolic disorders. PGM2's role is being actively studied, particularly concerning its unique substrate preferences and expression patterns.

Other names
PGM2phosphopentomutase
02

Biological functions

Glycogen biosynthesisGlycogen catabolismIntramolecular phosphotransferase activity (phosphotransferase: moves phosphate within a sugar molecule)Glucose metabolic process
03

Disease associations

Potential roles in metabolic disorders (as inferred for related phosphoglucomutases; none directly established for PGM2 yet)Other (mutations in related PHM enzymes cause metabolic diseases; role for PGM2 is under study)

Beyond the preview

Go deeper on Phosphoglucomutase 2 (PGM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoglucomutase 2 (PGM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call